导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -2.12% | 613/1050 |
| 近一周 | -2.50% | 635/1104 |
| 近一月 | 0.08% | 83/1102 |
| 近一季 | 1.46% | 190/1092 |
| 近半年 | -6.80% | 675/1070 |
| 近一年 | -1.19% | 610/1018 |
| 近两年 | 27.74% | 700/926 |
| 近三年 | 16.20% | 533/834 |
| 成立以来 | 33.90% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-0.24% 504/1070 |
-7.39% 851/1101 |
- - |
- - |
| 2025 | 9.91% 831/1065 |
-2.16% 918/1014 |
-0.53% 730/1038 |
11.69% 817/1050 |
1.11% 389/1065 |
| 2024 | 15.54% 160/1011 |
3.39% 150/960 |
1.35% 226/983 |
12.74% 404/991 |
-2.19% 467/1011 |
| 2023 | 6.81% 33/952 |
10.32% 107/880 |
3.09% 68/895 |
-0.56% 102/915 |
-5.55% 563/952 |
| 2022 | -2.79% 28/867 |
-3.21% 18/773 |
2.46% 650/806 |
-7.61% 124/845 |
6.09% 162/867 |
| 2021 | 17.93% 162/740 |
7.32% 26/580 |
-1.25% 555/659 |
6.56% 95/704 |
4.43% 247/740 |
| 2020 | 28.93% 353/554 |
-4.72% 280/419 |
7.43% 409/466 |
16.44% 122/517 |
8.18% 388/554 |
| 2019 | 33.89% 268/410 |
16.00% 992/1149 |
-0.73% 430/1231 |
8.04% 146/390 |
7.61% 256/410 |
| 2018 | -34.48% 265/349 |
- - |
- - |
- - |
-13.32% 774/1080 |
| 2017 | -11.15% 194/285 |
- - |
- - |
- - |
- - |
| 2016 | -36.94% 151/205 |
- - |
- - |
- - |
- - |
| 2015 | 35.21% 43/151 |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8316 | 54.00% |
| 招商前沿医疗保健股票C | 0.7978 | 53.69% |
| 招商医药健康产业股票 | 2.5730 | 48.73% |
| 嘉实医疗保健股票 | 2.5780 | 39.05% |
| 广发医药精选股票A | 1.3132 | 38.48% |
| 广发医药精选股票C | 1.2923 | 38.32% |
| 前海开源公共卫生股票A | 0.4690 | 37.42% |
| 前海开源公共卫生股票C | 0.4590 | 37.30% |
| 交银医药创新股票C | 3.0594 | 35.86% |
| 交银医药创新股票A | 2.8810 | 32.85% |
| 工银创新动力股票 VS. 东吴新产业精选股票A(580008) |